Barclays analyst Mathieu Robilliard downgrades Iridium Comms (NASDAQ:IRDM) from Overweight to Equal-Weight and lowers the price target from $48 to $45.
Citigroup Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $15
Citigroup analyst Tyler Radke initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $15.